Physician profile
William C Fix
NPI 1063972040
$1,563.50
in general payments reported to CMS, 2019-2025
19 companies · $423 in 2025
The $423 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $111 · 2022: $220 · 2023: $243 · 2024: $566 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,232.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,232.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $380.64 | 2021-2025 | |
| Dermavant Sciences, INC. | $198.84 | 2023 | Vtama |
| Merz North America, INC. | $171.27 | 2024 | |
| Incyte Corporation | $165.64 | 2022-2024 | Opzelura |
| Janssen Biotech, INC. | $106.26 | 2024-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $84.51 | 2025 | |
| Genzyme Corporation | $60.81 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $58.78 | 2024 | Sotyktu |
| Organon LLC | $48.26 | 2025 | Vtama |
| Pfizer INC. | $48.04 | 2024 | |
| Lilly USA, LLC | $39.33 | 2024 | Taltz, Ebglyss |
| Almirall LLC | $34.07 | 2025 | Seysara, Klisyri |
| Regeneron Healthcare Solutions, INC. | $32.22 | 2022-2024 | Dupixent |
| Amgen INC. | $24.10 | 2025 | Otezla |
| Ucb, INC. | $23.17 | 2025 | Bimzelx |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Botanix Sb INC | $22.89 | 2025 | Sofdra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.32 | 2024 | Spevigo |
| Galderma Laboratories, L.P. | $21.31 | 2025 | Nemluvio |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $21.04 | 2024 | Cabtreo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Fix listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.